Irinotecan Suppliers & Bulk Manufacturers

Available Forms: Injection/Infusion Solution

Available Strengths: 100 mg/5 mL, 300 mg/15 mL

Reference Brands: Camptosar® (US & EU)

Category: Oncology Cancer Care

Irinotecan is a chemotherapy drug used to treat cancers like colorectal, ovarian, and lung cancer. Available as an intravenous solution in 100 mg/5 mL and 300 mg/15 mL strengths, it is marketed as Camptosar® by Pfizer, with generic versions like Irinotecan Accord and Irinotecan Mylan. Widely sourced by B2B pharmaceutical wholesalers in the US and EU, it ensures reliable supply, GMP compliance, and competitive pricing for oncology centers. Irinotecan is available in Injection/Infusion Solution and strengths such as 100 mg/5 mL, 300 mg/15 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Irinotecan is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Irinotecan can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Irinotecan is an essential chemotherapy drug used in the treatment of various cancers, including colorectal, ovarian, and lung cancer. As a topoisomerase I inhibitor, it blocks DNA replication in cancer cells, preventing tumor growth. Available in intravenous (IV) solution forms, it is commonly provided in 100 mg/5 mL and 300 mg/15 mL strengths. Marketed under the brand Camptosar® by Pfizer, as well as in generic versions such as Irinotecan Accord and Irinotecan Mylan, it is widely sourced by B2B pharmaceutical wholesalers across the US and EU, ensuring reliable supply, GMP compliance, and competitive pricing for oncology centers.